Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)

@article{Demirkaya2016DevelopmentAI,
  title={Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)},
  author={Erkan Demirkaya and Cengizhan Açikel and Philip J. Hashkes and Marco Gattorno and Ahmet Gul and Huri Ozdogan and Turker Turker and Omer Karadag and Avi Livneh and Eldad Ben-Chetrit and Seza Ozen},
  journal={Annals of the Rheumatic Diseases},
  year={2016},
  volume={75},
  pages={1051 - 1056}
}
Objective To develop widely accepted international severity score for children and adult patients with familial Mediterranean fever (FMF) that can be easily applied, in research and clinical practice. Methods Candidate severity criteria were suggested by several FMF expert physicians. After three rounds of Delphi survey, the candidate criteria, defined by the survey, were discussed by experts in a consensus meeting. Each expert brought data of clinical manifestations, laboratory findings and… 
How to define disease severity accurately in patients with familial Mediterranean fever
TLDR
It is suggested that it is important to use validated outcome measures in any type of the study to achieve standardization and quantitative definition of patient’s well-being in the era of patient care as well as clinical research.
Disease Severity and Genotype Affect Physical Growth in Children With Familial Mediterranean Fever.
TLDR
The growth parameters in children with familial Mediterranean fever according to disease characteristics including genotype and disease severity by a recently validated tool by using a next-generation sequencing platform are analyzed to avoid growth disturbances.
Is the performance of the international severity scoring system for familial mediterranean fever in children better than other scoring systems?
TLDR
The aim of this study is to determine the disease severity of FMF patients according to the Pras, Mor, and International Severity Scoring System for Familial Mediterranean Fever (ISSF) scoring systems and to evaluate the consistency of these three systems.
Familial Mediterranean Fever (FMF): a single centre retrospective study in Amsterdam.
TLDR
Familial Mediterranean Fever in Amsterdam is diagnosed in relatively young patients and the delay to diagnosis is 8.2 years, suggesting that ancestry is more important than environment.
Evaluation of the international severity score for FMF (ISSF) scores in Turkish children diagnosed with FMF: a single-center experience
TLDR
The newly developed international severity score for FMF (ISSF) appears as a suitable and effective tool for the physicians in the follow-up of the disease severity in pediatric FMF patients and the addition of pathogenic mutations and inheritance model to the ISSF scoring system as important determinants of disease severity can be evaluated in future studies.
Factors associated with damage in patients with familial Mediterranean fever.
TLDR
This study is the first to apply comprehensive damage indexes to FMF patients and identified predictors of damage, including factors linked to a severe FMF phenotype, which justify the concerns about musculoskeletal pain and might point to the need for re-evaluation of ADDI.
The Influence of Concomitant Disorders on Disease Severity of Familial Mediterranean Fever in Children.
TLDR
It is indicated that concomitant diseases, particularly JIA, influence FMF severity and it may be beneficial to focus on diagnosis and treatment of comorbid inflammatory diseases, which may worsen the course of FMF.
Compliance of Familial Mediterranean Fever Patients With Regular Follow-up Visits and Associated Factors.
TLDR
A family history of FMF in parents, the absence of a family history in siblings, treatment with biologic agents, concomitant medication use, multisite involvement during FMF attacks, and treatment satisfaction were independent predictors of visit compliance.
Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever?
TLDR
The disease characteristics of FMF may differ between patients with different age at symptom onset, and treatment compliance which is critical for prevention of amyloidosis in FMF should be questioned especially in adolescent patients.
Familial Mediterranean fever: Health-related quality of life and associated variables in a national cohort
TLDR
Female sex, smoking, lower educational status, more severe disease, fatigue, and functional impairment were associated with poor QoL in patients with Familial Mediterranean Fever.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
Evaluation of disease severity in familial Mediterranean fever.
A new set of criteria for the diagnosis of familial Mediterranean fever in childhood.
TLDR
It was demonstrated that although the Tel Hashomer criteria were successful in diagnosing the FMF patients in childhood, its specificity was definitely low in children.
Evaluation of the current disease severity scores in paediatric FMF: is it necessary to develop a new one?
TLDR
Concerns are raised about the reliability of these scoring systems in children since certain mutations are prone to severe disease and there is a need to develop a scoring system in children based on a prospective registry.
Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever.
TLDR
Limited genetic molecular testing for MEFV mutations may explain some of the FMF clinical variability, but is diagnostically ineffective; the use of clinical criteria remains essential in establishing the diagnosis of FMF.
Severity scoring system for paediatric FMF
TLDR
A key messages of the study was the lack of consistency between the current severity scoring tools for paedi‐ atric FMF, and the results of each scoring system according to the country of residence demonstrated disagreement.
Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease
TLDR
The results suggest that the environment affects the phenotype of a monogenic disease of the innate inflammatory pathway as some patients do not develop the complication of secondary amyloidosis.
Criteria to define response to therapy in paediatric rheumatic diseases
TLDR
The proposed core sets and definitions of improvement incorporate clinically meaningful change in a composite endpoint for the evaluation of global response to therapy in the major PRD.
Quality of life of patients with familial Mediterranean fever.
TLDR
The QOL of FMF patients was found to be impaired compared to healthy controls, and further studies are needed to determine the exact factors affecting the quality of life ofFMF patients.
Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children
TLDR
Eastern Mediterranean FMF patients have a milder disease phenotype once they migrate to Europe, reflecting the effect of environment on the expression of a monogenic disease.
Evaluation of the Current Disease Scoring Systems in Familial Mediterranean Fever
TLDR
Health is a multidimensional, subjective, and qualitatively natured concept that is usually expressed in terms of presence or absence of life-threatening illness, risk factors for mortality, activity and severity of disease, and overall health-related performance.
...
1
2
3
4
...